vs
Newsmax Inc.（NMAX）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是Newsmax Inc.的1.3倍（$69.8M vs $52.2M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs -5.7%，领先389.7%）
纽斯马克斯公司是一家总部位于美国的媒体广播企业，提供新闻报道、政治评论、观点内容及生活类节目，通过有线电视、官网、移动应用和流媒体平台分发内容，主要面向美国本土受众，核心内容板块侧重保守立场的时事资讯。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
NMAX vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.3倍
$52.2M
净利率更高
RIGL
高出389.7%
-5.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $52.2M | $69.8M |
| 净利润 | $-3.0M | $268.1M |
| 毛利率 | 36.7% | 91.5% |
| 营业利润率 | -9.0% | 33.2% |
| 净利率 | -5.7% | 384.0% |
| 营收同比 | — | 21.2% |
| 净利润同比 | — | 1769.2% |
| 每股收益（稀释后） | $0.15 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NMAXRIGL
| Q4 25 | $52.2M | $69.8M | ||
| Q3 25 | $45.3M | $69.5M | ||
| Q2 25 | $46.4M | $101.7M | ||
| Q1 25 | $45.3M | $53.3M | ||
| Q4 24 | — | $57.6M | ||
| Q3 24 | — | $55.3M | ||
| Q2 24 | — | $36.8M | ||
| Q1 24 | — | $29.5M |
净利润NMAXRIGL
| Q4 25 | $-3.0M | $268.1M | ||
| Q3 25 | $-4.1M | $27.9M | ||
| Q2 25 | $-75.2M | $59.6M | ||
| Q1 25 | $-17.2M | $11.4M | ||
| Q4 24 | — | $14.3M | ||
| Q3 24 | — | $12.4M | ||
| Q2 24 | — | $-1.0M | ||
| Q1 24 | — | $-8.2M |
毛利率NMAXRIGL
| Q4 25 | 36.7% | 91.5% | ||
| Q3 25 | 35.3% | 93.2% | ||
| Q2 25 | 38.0% | 95.6% | ||
| Q1 25 | 47.8% | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率NMAXRIGL
| Q4 25 | -9.0% | 33.2% | ||
| Q3 25 | -15.9% | 40.9% | ||
| Q2 25 | -164.5% | 60.1% | ||
| Q1 25 | -25.5% | 23.9% | ||
| Q4 24 | — | 28.9% | ||
| Q3 24 | — | 25.4% | ||
| Q2 24 | — | 1.2% | ||
| Q1 24 | — | -23.6% |
净利率NMAXRIGL
| Q4 25 | -5.7% | 384.0% | ||
| Q3 25 | -9.1% | 40.2% | ||
| Q2 25 | -161.9% | 58.6% | ||
| Q1 25 | -38.0% | 21.5% | ||
| Q4 24 | — | 24.9% | ||
| Q3 24 | — | 22.5% | ||
| Q2 24 | — | -2.8% | ||
| Q1 24 | — | -27.9% |
每股收益（稀释后）NMAXRIGL
| Q4 25 | $0.15 | $14.11 | ||
| Q3 25 | $-0.03 | $1.46 | ||
| Q2 25 | $-0.59 | $3.28 | ||
| Q1 25 | $-0.49 | $0.63 | ||
| Q4 24 | — | $0.82 | ||
| Q3 24 | — | $0.70 | ||
| Q2 24 | — | $-0.06 | ||
| Q1 24 | — | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $20.4M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $106.0M | $391.5M |
| 总资产 | $239.8M | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资NMAXRIGL
| Q4 25 | $20.4M | $155.0M | ||
| Q3 25 | $14.2M | $137.1M | ||
| Q2 25 | $33.8M | $108.4M | ||
| Q1 25 | $126.7M | $77.1M | ||
| Q4 24 | — | $77.3M | ||
| Q3 24 | — | $61.1M | ||
| Q2 24 | — | $49.1M | ||
| Q1 24 | — | $49.5M |
总债务NMAXRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益NMAXRIGL
| Q4 25 | $106.0M | $391.5M | ||
| Q3 25 | $106.0M | $117.6M | ||
| Q2 25 | $106.9M | $81.9M | ||
| Q1 25 | $177.4M | $18.6M | ||
| Q4 24 | — | $3.3M | ||
| Q3 24 | — | $-14.6M | ||
| Q2 24 | — | $-29.9M | ||
| Q1 24 | — | $-31.7M |
总资产NMAXRIGL
| Q4 25 | $239.8M | $513.6M | ||
| Q3 25 | $233.3M | $242.5M | ||
| Q2 25 | $259.8M | $206.7M | ||
| Q1 25 | $278.2M | $176.0M | ||
| Q4 24 | — | $164.0M | ||
| Q3 24 | — | $139.4M | ||
| Q2 24 | — | $128.4M | ||
| Q1 24 | — | $126.5M |
负债/权益比NMAXRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $2.6M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $1.8M | — |
| 自由现金流率自由现金流/营收 | 3.4% | — |
| 资本支出强度资本支出/营收 | 1.7% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $-107.1M | — |
8季度趋势，按日历期对齐
经营现金流NMAXRIGL
| Q4 25 | $2.6M | $22.0M | ||
| Q3 25 | $-68.1M | $24.0M | ||
| Q2 25 | $-23.2M | $30.5M | ||
| Q1 25 | $-15.7M | $-893.0K | ||
| Q4 24 | — | $14.5M | ||
| Q3 24 | — | $21.7M | ||
| Q2 24 | — | $302.0K | ||
| Q1 24 | — | $-5.0M |
自由现金流NMAXRIGL
| Q4 25 | $1.8M | — | ||
| Q3 25 | $-69.2M | — | ||
| Q2 25 | $-23.8M | — | ||
| Q1 25 | $-15.8M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率NMAXRIGL
| Q4 25 | 3.4% | — | ||
| Q3 25 | -152.9% | — | ||
| Q2 25 | -51.3% | — | ||
| Q1 25 | -34.9% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度NMAXRIGL
| Q4 25 | 1.7% | — | ||
| Q3 25 | 2.4% | — | ||
| Q2 25 | 1.3% | — | ||
| Q1 25 | 0.2% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率NMAXRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NMAX
| Advertising | $33.9M | 65% |
| Affiliate Fee | $8.3M | 16% |
| Subscription And Circulation | $6.2M | 12% |
| Products | $2.6M | 5% |
| Supplement Sales | $1.1M | 2% |
RIGL
暂无分部数据
